These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9296177)

  • 21. MR perfusion and diffusion imaging in the follow-up of recurrent glioblastoma treated with dendritic cell immunotherapy: a pilot study.
    Vrabec M; Van Cauter S; Himmelreich U; Van Gool SW; Sunaert S; De Vleeschouwer S; Suput D; Demaerel P
    Neuroradiology; 2011 Oct; 53(10):721-31. PubMed ID: 21107549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serial MR imaging of intracranial metastases after radiosurgery.
    Hawighorst H; Essig M; Debus J; Knopp MV; Engenhart-Cabilic R; Schönberg SO; Brix G; Zuna I; van Kaick G
    Magn Reson Imaging; 1997; 15(10):1121-32. PubMed ID: 9408133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Encapsulation of packaging cell line results in successful retroviral-mediated transfer of a suicide gene in vivo in an experimental model of glioblastoma.
    Martinet O; Schreyer N; Reis ED; Joseph JM
    Eur J Surg Oncol; 2003 May; 29(4):351-7. PubMed ID: 12711288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ²³Na-MRI of recurrent glioblastoma multiforme after intraoperative radiotherapy: technical note.
    Haneder S; Giordano FA; Konstandin S; Brehmer S; Buesing KA; Schmiedek P; Schad LR; Wenz F; Schoenberg SO; Ong MM
    Neuroradiology; 2015 Mar; 57(3):321-6. PubMed ID: 25428586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perspectives for the gene therapy of malignant gliomas by suicide gene transfer.
    Di Meco F; Benedetti S; Colombo MP; Finocchiaro G
    J Neurosurg Sci; 1997 Sep; 41(3):227-34. PubMed ID: 9444575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Location of subventricular zone recurrence and its radiation dose predicts survival in patients with glioblastoma.
    Weinberg BD; Boreta L; Braunstein S; Cha S
    J Neurooncol; 2018 Jul; 138(3):549-556. PubMed ID: 29546530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiforme.
    Rainov NG; Kramm CM; Banning U; Riemann D; Holzhausen HJ; Heidecke V; Burger KJ; Burkert W; Körholz D
    Gene Ther; 2000 Nov; 7(21):1853-8. PubMed ID: 11110418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re-irradiation after gross total resection of recurrent glioblastoma : Spatial pattern of recurrence and a review of the literature as a basis for target volume definition.
    Straube C; Elpula G; Gempt J; Gerhardt J; Bette S; Zimmer C; Schmidt-Graf F; Meyer B; Combs SE
    Strahlenther Onkol; 2017 Nov; 193(11):897-909. PubMed ID: 28616821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 gene--a phase I/II clinical protocol.
    Ren H; Boulikas T; Lundstrom K; Söling A; Warnke PC; Rainov NG
    J Neurooncol; 2003; 64(1-2):147-54. PubMed ID: 12952295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffusion Magnetic Resonance Imaging Phenotypes Predict Overall Survival Benefit From Bevacizumab or Surgery in Recurrent Glioblastoma With Large Tumor Burden.
    Patel KS; Everson RG; Yao J; Raymond C; Goldman J; Schlossman J; Tsung J; Tan C; Pope WB; Ji MS; Nguyen NT; Lai A; Nghiemphu PL; Liau LM; Cloughesy TF; Ellingson BM
    Neurosurgery; 2020 Oct; 87(5):931-938. PubMed ID: 32365185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene stereotactic neurosurgery for recurrent malignant gliomas.
    Colombo F; Zanusso M; Casentini L; Cavaggioni A; Franchin E; Calvi P; Palù G
    Stereotact Funct Neurosurg; 1997; 68(1-4 Pt 1):245-51. PubMed ID: 9711724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limited efficacy of gene transfer in herpes simplex virus-thymidine kinase/ganciclovir gene therapy for brain tumors.
    Hadaczek P; Mirek H; Berger MS; Bankiewicz K
    J Neurosurg; 2005 Feb; 102(2):328-35. PubMed ID: 15739562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies.
    Staquicini FI; Smith TL; Tang FHF; Gelovani JG; Giordano RJ; Libutti SK; Sidman RL; Cavenee WK; Arap W; Pasqualini R
    Cancer Gene Ther; 2020 May; 27(5):301-310. PubMed ID: 31130731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration.
    Niranjan A; Moriuchi S; Lunsford LD; Kondziolka D; Flickinger JC; Fellows W; Rajendiran S; Tamura M; Cohen JB; Glorioso JC
    Mol Ther; 2000 Aug; 2(2):114-20. PubMed ID: 10947938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extirpation of glioblastomas: MR and CT follow-up of residual tumor and regrowth patterns.
    Forsting M; Albert FK; Kunze S; Adams HP; Zenner D; Sartor K
    AJNR Am J Neuroradiol; 1993; 14(1):77-87. PubMed ID: 8381255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response patterns of recurrent glioblastomas treated with tumor-treating fields.
    Vymazal J; Wong ET
    Semin Oncol; 2014 Oct; 41 Suppl 6():S14-24. PubMed ID: 25213870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human malignant brain tumor response to herpes simplex thymidine kinase (HSVtk)/ganciclovir gene therapy.
    Izquierdo M; Martín V; de Felipe P; Izquierdo JM; Pérez-Higueras A; Cortés ML; Paz JF; Isla A; Blázquez MG
    Gene Ther; 1996 Jun; 3(6):491-5. PubMed ID: 8789798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent glioblastoma: volumetric assessment and stratification of patient survival with early posttreatment magnetic resonance imaging in patients treated with bevacizumab.
    Huang RY; Rahman R; Hamdan A; Kane C; Chen C; Norden AD; Reardon DA; Mukundun S; Wen PY
    Cancer; 2013 Oct; 119(19):3479-88. PubMed ID: 23821555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors.
    Schäfer N; Gielen GH; Rauschenbach L; Kebir S; Till A; Reinartz R; Simon M; Niehusmann P; Kleinschnitz C; Herrlinger U; Pietsch T; Scheffler B; Glas M
    J Transl Med; 2019 Mar; 17(1):96. PubMed ID: 30894200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [1H-MR Spectroscopy of brain tumors in the course of radiation therapy: Use of fast spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence].
    Träber F; Block W; Flacke S; Lamerichs R; Schüller H; Urbach H; Keller E; Schild HH
    Rofo; 2002 Jan; 174(1):33-42. PubMed ID: 11793282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.